News | March 25, 2010

ASTRO Elects 2010 Corporate Advisory Council

March 25, 2010 - The American Society for Radiation Oncology (ASTRO) has elected the officials to serve on ASTRO's Corporate Advisory Council.

The goal of the council is to focus on issues of mutual concern to all corporate members and to increase awareness of radiation therapy and advance the science and practice of radiation therapy in the treatment of cancer.

The Corporate Advisory Council is a representative body of ASTRO's corporate membership, consisting of nearly 100 equipment, device and pharmaceutical companies who are involved in radiation therapy. These elected council seats are balanced among small-, medium- and large-sized corporations and represent a cross section of the radiation oncology industry.
A complete council listing with term expiration is as follows:
Accuray, Inc. 2010
Alliance Oncology 2012
BrainLAB 2010
Calypso Medical 2011
Elekta 2012
GE Healthcare 2010
Multidata Systems 2010
Revenue Cycle, Inc. 2012
Standard Imaging 2011
Varian Medical Systems 2011

ASTRO's corporate membership elected these companies, which was approved by the ASTRO Board of Directors.

"It is very important for ASTRO to maintain good working relationships with our industry partners as these companies continue to provide innovate tools that help our physician members provide care to our patients," said Deborah Kuban, M.D., FASTRO, chair of ASTRO's Corporate Relations Committee and a radiation oncologist at M.D. Anderson Cancer Center in Houston. "We believe that fostering this forum helps our society successfully connect the patient, doctor and technology in delivering cancer treatment."

For more information: www.astro.org/CorporateRelations/

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...